Variant report
Variant | nsv348880 |
---|---|
Chromosome Location | chr6:65902222-65911707 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs538998139 | chr6:65902240-65902241 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs544518968 | chr6:65902252-65902253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs542625372 | chr6:65902299-65902300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs377595436 | chr6:65902300-65902301 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs559284220 | chr6:65902305-65902306 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs577758875 | chr6:65902310-65902311 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs540186896 | chr6:65902378-65902379 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs9453220 | chr6:65902462-65902463 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs192268083 | chr6:65902463-65902464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs564960103 | chr6:65902512-65902513 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs542826231 | chr6:65902541-65902542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs182344128 | chr6:65902593-65902594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs564601284 | chr6:65902610-65902611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs531678485 | chr6:65902620-65902621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs535087 | chr6:65902642-65902643 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs140482603 | chr6:65902728-65902729 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs117032310 | chr6:65902746-65902747 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs527689448 | chr6:65902757-65902758 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs547354444 | chr6:65902762-65902763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs186922391 | chr6:65902772-65902773 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs147065644 | chr6:65902779-65902780 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs550233879 | chr6:65902799-65902800 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs147663410 | chr6:65902837-65902838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs73741256 | chr6:65902839-65902840 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs146145315 | chr6:65902857-65902858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs572736244 | chr6:65902896-65902897 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs533784341 | chr6:65902908-65902909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs553459448 | chr6:65902910-65902911 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs573557487 | chr6:65902914-65902915 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs542388858 | chr6:65902925-65902926 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs191825756 | chr6:65902936-65902937 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs184214606 | chr6:65902944-65902945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs544766815 | chr6:65902950-65902951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs75602302 | chr6:65902965-65902966 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs527554821 | chr6:65902989-65902990 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs138669975 | chr6:65903002-65903003 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs149326954 | chr6:65903008-65903009 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs530096908 | chr6:65903017-65903018 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs541949078 | chr6:65903023-65903024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs550052721 | chr6:65903037-65903038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs570084763 | chr6:65903101-65903102 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs560706 | chr6:65903127-65903128 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs552768475 | chr6:65903142-65903143 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs566395542 | chr6:65903190-65903191 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs568300011 | chr6:65903300-65903301 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs548031967 | chr6:65903313-65903314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs9453221 | chr6:65903322-65903323 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs555225939 | chr6:65903323-65903324 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs189019881 | chr6:65903327-65903328 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs9453222 | chr6:65903328-65903329 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Epilepsy | 20502679 | CNVD |
Dyslexia | 22102821 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Schizophrenia | 23813976 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:65901800-65905200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr6:65902000-65910200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
3 | chr6:65909200-65909600 | Enhancers | HUVEC | blood vessel |
4 | chr6:65910200-65910400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr6:65911600-65913000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |